3-methylisoxazole-5-carbonyl chloride; 97%; 250mg; F.W.: 145.54; C5H4ClNO2; M.P.: 39-41; Primary CAS: 49783-72-4
-
P/N:
CC27002CB
- UOM: EA
- UOM Qty: 1
|
|
4-Methyl-2-phenyl-5-pyrimidinecarboxylic acid; 97%; 5g; F.W.: 214.22; C12H10N2O2; M.P.: 242-243; Primary CAS: 103249-79-2
-
P/N:
CC20201DE
- UOM: EA
- UOM Qty: 1
|
|
N-Methyl-(4-methyl-2-phenyl-1,3-oxazol-5-ylmethyl)amine; 97%; 1g; F.W.: 202.26; C12H14N2O
-
P/N:
CC18146DA
- UOM: EA
- UOM Qty: 1
|
|
N-Methyl-(4-methyl-2-phenyl-1,3-oxazol-5-ylmethyl)amine; 97%; 250mg; F.W.: 202.26; C12H14N2O
-
P/N:
CC18146CB
- UOM: EA
- UOM Qty: 1
|
|
4-Methyl-2-phenyl-1,3-oxazole-5-carboxylic acid 97%; 97%; 1g; F.W.: 203.20; C11H9NO3; Primary CAS: 91137-55-2
-
P/N:
CC18101DA
- UOM: EA
- UOM Qty: 1
|
|
4-Methyl-2-phenyl-1,3-oxazole-5-carboxylic acid 97%; 97%; 250mg; F.W.: 203.20; C11H9NO3; Primary CAS: 91137-55-2
-
P/N:
CC18101CB
- UOM: EA
- UOM Qty: 1
|
|
4-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinyl]morpholine; 97%; 5g; F.W.: 290.16; C15H23BN2O3; M.P.: 132-135; Primary CAS: 485799-04-0
-
P/N:
CC17539DE
- UOM: EA
- UOM Qty: 1
|
|
pentafluorophenyl 4-morpholinobenzoate; 97%; 1g; F.W.: 373.27; C17H12F5NO3; M.P.: 144-146.5; Primary CAS: 921938-51-4
-
P/N:
CC17426DA
- UOM: EA
- UOM Qty: 1
|
|
pentafluorophenyl 4-morpholinobenzoate; 97%; 250mg; F.W.: 373.27; C17H12F5NO3; M.P.: 144-146.5; Primary CAS: 921938-51-4
-
P/N:
CC17426CB
- UOM: EA
- UOM Qty: 1
|
|
N,5-Dimethyl-1-phenyl-(1H-pyrazol-4-ylmethyl)amine; 97%; 1g; F.W.: 201.27; C12H15N3
-
P/N:
CC15546DA
- UOM: EA
- UOM Qty: 1
|
|
